51-60 items (total 701)
Published At December 05, 2024
Development of a Workflow for Fault-Tolerant Quantum Computers for Quantum Chemical Calculations of Large Molecules—Paper Demonstrating the Validity of the Workflow with Three Types of Molecules, Including Benzene, Published in the International Academic Journal "Physical Chemistry Chemical Physics"—
Public Relations Office
Published At December 05, 2024
SFC EXPO Held on November 23-24!
Faculty of Environment and Information Studies/Faculty of Policy Management/Graduate School of Media and Governance
Published At December 02, 2024
Successful Blasting at Tunnel Face Using an "Automatic Explosive Loading System"—Applying Haptic Technology "Real Haptics®" to Enable Safe Operations from Outside the Tunnel—
Public Relations Office
Published At November 29, 2024
An Information Analysis Program to Elucidate Complex and Diverse Lipid Metabolism: Unraveling Lipid Structure and Localization through Multimodal Mass Spectrometry
Public Relations Office
Published At November 29, 2024
KEIO TECHNO-MALL 2024 (The 25th KEIO TECHNO-MALL) to be Held on December 13
Public Relations Office
Published At November 28, 2024
Development of the World's First Mouse Model that Reproduces the Immune Environment of NK Cell Lymphoma—Identifying the Cell of Origin and Paving the Way for New Therapies for an Intractable Disease
Public Relations Office
Published At November 26, 2024
29th Keio Medical Science Prize Award Ceremony
Public Relations Office
Published At November 25, 2024
Decomposing Plastic Straws Difficult to Biodegrade in Nature! Multiple Degrading Bacteria Suitable for P-Life, a Plastic Additive that Imparts Biodegradability, Discovered in Soil from Nishi-Kamakura Elementary School
Public Relations Office
Published At November 22, 2024
NAA, JAL, and Keio University to Hold First-Ever Joint Earthquake Disaster Drill at Narita Airport on December 6
Public Relations Office
Published At November 21, 2024
Establishment of a Screening Method for Alzheimer's Disease Using a Simple Dementia Sign and Questionnaire Set—Also Applicable for Determining Lecanemab Eligibility—
Public Relations Office